Abstract
Purpose
Propose a five-step multigating, multimodal procedure for research case definition and identification of attention-deficit/hyperactivity disorder (AD/HD) in population-based epidemiologic studies.Methods
Subjects included a birth cohort of all children born between 1976 and 1982 who remained in Rochester after age 5. Screening for AD/HD required 4 steps, using these sources: school/medical records, computerized diagnostic index, and private psychiatry records. In step 5, research criteria were applied to potential cases. The model for defining cases used combinations of three categories of information (DSM-IV, questionnaire, clinical diagnosis). Validity was tested by comparing medication treatment, substance abuse, school outcomes, and comorbidities between cases who did or did not meet DSM-IV criteria.Results
Among 5718 subjects, 1344 potential cases were identified; 379 met research criteria. No difference in gender, treatment, school outcome, or professional making clinical diagnoses was found between cases who did (N=228) and did not (N=151) meet DSM-IV criteria. However, cases not meeting DSM-IV criteria were more inattentive (33.8% vs. 17.1%; p < 0.001), older (age 12.8 vs. 10.5 years; p=0.01), with less substance abuse (15.2% vs. 26.3%; p < 0.001) and psychiatric comorbidities (43.1% vs. 54.4%; p=0.031).Conclusions
If only DSM-IV criteria were applied, 151 cases would not have been identified. This study underscores the importance of using multiple sources and combinations of documented information for case definition and identification.References
Articles referenced by this article (30)
Title not supplied
1994
American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision Washington, DC 2000.
How common is attention-deficit/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, Minn.
Arch Pediatr Adolesc Med, (3):217-224 2002
MED: 11876664
Economic implications of attention-deficit hyperactivity disorder for healthcare systems.
Pharmacoeconomics, (17):1239-1262 2003
MED: 14986737
Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder.
JAMA, (1):60-66 2001
MED: 11150110
Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
JAMA, (14):1100-1107 1998
MED: 9546570
Clinical Practice Guideline: Diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder
Pediatrics 2000
Potential influence of migration bias in birth cohort studies.
Mayo Clin Proc, (11):1053-1061 1998
MED: 9818038
Incidence of reading disability in a population-based birth cohort, 1976-1982, Rochester, Minn.
Mayo Clin Proc, (11):1081-1092 2001
MED: 11702896
Show 10 more references (10 of 30)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1016/j.annepidem.2004.12.004
Article citations
Risk factors for development of long-term mood and anxiety disorder after pediatric traumatic brain injury: a population-based, birth cohort analysis.
Brain Inj, 36(6):722-732, 23 May 2022
Cited by: 3 articles | PMID: 35604956 | PMCID: PMC10364060
Co-occurring Mental Disorders in Transitional Aged Youth With Substance Use Disorders - A Narrative Review.
Front Psychiatry, 13:827658, 24 Feb 2022
Cited by: 3 articles | PMID: 35280170 | PMCID: PMC8907594
Review Free full text in Europe PMC
Utility of medical record diagnostic codes to ascertain attention-deficit/hyperactivity disorder and learning disabilities in populations of children.
BMC Pediatr, 20(1):510, 07 Nov 2020
Cited by: 5 articles | PMID: 33158434 | PMCID: PMC7648408
Long-Term Suicide Risk of Children and Adolescents With Attention Deficit and Hyperactivity Disorder-A Systematic Review.
Front Psychiatry, 11:557909, 21 Dec 2020
Cited by: 10 articles | PMID: 33408650 | PMCID: PMC7779592
Review Free full text in Europe PMC
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.
Cochrane Database Syst Rev, 5:CD012069, 09 May 2018
Cited by: 127 articles | PMID: 29744873 | PMCID: PMC6494554
Review Free full text in Europe PMC
Go to all (37) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Predictive validity of ICD-10 hyperkinetic disorder relative to DSM-IV attention-deficit/hyperactivity disorder among younger children.
J Child Psychol Psychiatry, 47(5):472-479, 01 May 2006
Cited by: 33 articles | PMID: 16671930
Long-term school outcomes for children with attention-deficit/hyperactivity disorder: a population-based perspective.
J Dev Behav Pediatr, 28(4):265-273, 01 Aug 2007
Cited by: 134 articles | PMID: 17700078
Poor utility of the age of onset criterion for DSM-IV attention deficit/hyperactivity disorder: recommendations for DSM-V and ICD-11.
J Child Psychol Psychiatry, 49(9):942-949, 28 Jun 2008
Cited by: 30 articles | PMID: 18564071
Evaluating the evidence for and against the overdiagnosis of ADHD.
J Atten Disord, 11(2):106-113, 01 Sep 2007
Cited by: 68 articles | PMID: 17709814
Review
Funding
Funders who supported this work.
NIAMS NIH HHS (1)
Grant ID: AR30582
NICHD NIH HHS (1)
Grant ID: HD29745